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Key points
 Ghrelin, a hunger signalling peptide derived from the peripheral tissues, overcomes the satiety
signals evoked by anorexigenic molecules, such as cholecystokinin (CCK) and leptin, to
stimulate feeding.
 Using in vivo and in vitro electrophysiological techniques, we show that ghrelin hyperpolarizes
neurons and inhibits currents evoked by leptin and CCK-8.
 Administering a KATP channel antagonist or silencing Kir6.2, a major subunit of the KATP
channel, abolished ghrelin inhibition.
 The inhibitory actions of ghrelin were also abolished by treating the vagal ganglia neurons with
pertussis toxin, as well as phosphatidylinositol 3-kinase (PI3K) or extracellular signal-regulated
kinase 1 and 2 (Erk1/2) small interfering RNA.
 Feeding experiments showed that silencing Kir6.2 in the vagal ganglia abolished the orexigenic
actions of ghrelin.
 These data indicate that ghrelin modulates vagal ganglia neuron excitability by
activating KATP conductance via the growth hormone secretagogue receptor subtype
1a–Gαi–PI3K–Erk1/2–KATP pathway.
 This provides a mechanism to explain the actions of ghrelin with respect to overcoming
anorexigenic signals that act via the vagal afferent pathways.
Abstract Ghrelin is the only known hunger signal derived from the peripheral tissues. Ghrelin
overcomes the satiety signals evoked by anorexigenic molecules, such as cholecystokinin (CCK)
and leptin, to stimulate feeding. The mechanisms by which ghrelin reduces the sensory signals
evoked by anorexigenic hormones, which act via the vagus nerve to stimulate feeding, are
unknown. Patch clamp recordings of isolated rat vagal neurons show that ghrelin hyperpolarizes
neurons by activating K+ conductance. Administering a KATP channel antagonist or silencing
Kir6.2, a major subunit of the KATP channel, abolished ghrelin inhibition in vitro and in vivo.
Patch clampstudies show that ghrelin inhibits currents evokedby leptin andCCK-8,whichoperate
through independent ionic channels. The inhibitory actions of ghrelin were abolished by treating
the vagal ganglia neurons with pertussis toxin, as well as phosphatidylinositol 3-kinase (PI3K) or
extracellular signal-regulated kinase 1 and 2 (Erk1/2) small interfering RNA. In vivo gene silencing
of PI3K andErk1/2 in the nodose ganglia prevented ghrelin inhibition of leptin- orCCK-8-evoked
vagal firing. Feeding experiments showed that silencing Kir6.2 in the vagal ganglia abolished the
orexigenic actions of ghrelin. These data indicate that ghrelin modulates vagal ganglia neuron
excitability by activating KATP conductance via the growth hormone secretagogue receptor sub-
type 1a–Gαi–PI3K–Erk1/2–KATP pathway. The resulting hyperpolarization renders the neurons
less responsive to signals evoked by anorexigenic hormones. This provides amechanism to explain
the actions of ghrelinwith respect to overcoming anorexigenic signals that act via the vagal afferent
pathways.
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Introduction
Ghrelin, which is released from gastric X/A-like (P/D1
in humans) endocrine cells in response to fasting, is
important in the regulation of feeding behaviour (Kojima
et al. 1999; Gnanapavan et al. 2002). Ghrelin is the only
known hunger-generated signal derived from the pe-
ripheral tissues. Peripheral administration of ghrelin in
animals stimulates food intake and increases acid and
protein secretion. It also increases gastric motility but
inhibits lipid metabolism (Tscho¨p et al. 2002; Nakazato
et al. 2001; Li et al. 2006; Tack et al. 2006; Kobashi et al.
2009).
Ghrelin signalling involves activation of the growth
hormone secretagogue receptor subtype 1A (GHS-R1a)
(Kojima et al. 1999), whose mRNA is expressed
in the neuron bodies of the vagal sensory ganglia
(Sakata et al. 2003). Kentish et al. (2011) traced vagal
afferents anterogradely to their terminals in the gastric
mucosa, and showed them to be in close apposition to
ghrelin-containing cells, suggesting that ghrelin signals
from the stomach are transmitted to the brain via
the vagus nerve (Date et al. 2002). Moreover, periph-
erally administered ghrelin diminishes vagal afferent
activity,whereas vagotomyorperivagal capsaicin abolishes
facilitation of feeding in both rodents and humans (Date
et al. 2002; 2005; le Roux et al. 2005). However, other
studies have shown that ghrelin acts in preautonomic
hypothalamus as well as in vagal brainstem nuclei to
modulatepancreatic secretion, gastricmotility and feeding
(Dickson & Luckman, 1997; Li et al. 2006; Cui et al.
2011; Swartz et al. 2014). These discrepancies may be a
result of differences in animal species and/or experimental
conditions. It is also conceivable that these different sites
may mediate the different actions of ghrelin. It has been
suggested that ghrelin acts via vagal afferent pathways
to modulate satiety, whereas the hypothalamic receptors
of ghrelin probably regulate long-term feeding behaviour
and energy metabolism (Schwarz et al. 1996).
Similar to the studies reported by Nakazato et al.
(2001), our preliminary studies demonstrate that ghrelin
mainly acts via vagal afferent pathways tomodulate satiety.
Cholecystokinin (CCK) (Smith et al. 1985) and leptin
(Barrachina et al. 1997) are also known to act via vagal
sensory pathways to regulate feeding. Ghrelin is reported
to reduce the satiety signal evoked by anorexigenic
molecules, such as leptin (Nakazato et al. 2001; Noqueiras
et al. 2004) and CCK (DeLartigue et al. 2012), which act
on the nodose ganglia to modulate feeding.
The mechanisms by which ghrelin exerts its inhibitory
effects on leptin and CCK are unknown. Because leptin
and CCK act via diverse signal transduction pathways
(Heldsinger et al. 2011) to activate nodose ganglia firing,
it is improbable that ghrelin acts by interrupting these
diverse signalling cascades. We propose that ghrelin
activates an intracellular transduction pathway altering
the electrophysiological properties of the nodose ganglia,
rendering it less responsive to anorexigenic peptide
stimulation.
KATP channels couple metabolism to electrical activities
(Proks & Ashcroft, 2009). An increased blood glucose
level leads to channel closure, membrane depolarization
and enhanced electrical activity (Grabauskas et al. 2010;
2013). Conversely, a decreased glucose concentration
opens KATP channels and reduces neuronal firing (Levin,
2001; Browning, 2013). It is conceivable that ghrelin
regulates nodose ganglia responsiveness to anorexigenic
signals through theopeningofKATP channels in thenodose
ganglia.
In the present study, we define a mechanism used
by ghrelin to modulate the excitability of the vagal
nodose ganglia, resulting in enhanced feeding. Western
blotting, patch clamp electrophysiological studies and
gene silencing techniques in cultured rat nodose ganglia
neurons, as well as in vivo single-cell electrical recordings
and feeding studies, show that ghrelin modulates the
excitability of vagal nodose ganglia by activating a KATP
conductance via the GSH-R1a–Gαi–phosphatidylinositol
3-kinase (PI3K)–extracellular signal-regulated kinase 1
and 2 (Erk1/2)–KATP pathway. This results in increased
feeding.
Methods
Ethical approval
All animal procedures were performed in accordance with
National Institutes of Health guidelines and with the
approval of the University Committee on Use and Care
of Animals at the University of Michigan.
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Retrograde tracing
Five Sprague–Dawley male rats (200 g; Harlan Labora-
tories, Indianapolis, IN, USA) were deeply anaesthetized
with a mixture of isoflurane in air as described pre-
viously (Grabauskas et al. 2010). Following laparotomy,
crystals of the retrograde tracer 1,1ʹ-dioctadecyl-3,3,
3ʹ,3ʹ-tetramethylindocarbocyanine perchlorate (DiI; Life
Technologies, Invitrogen, Grand Island, NY, USA) were
applied to the duodenum. To confine the dye to the
application site, the DiI crystals were embedded in a
fast curing epoxy resin that was allowed to harden
for approximately 5 min. The surgical area was then
washed with warm sterile saline, and the wound was
closed with nylon sutures (4-0). Analgesic buprenophrine
(0.3 mg kg−1) was administered. Each animal was housed
in a separate cage. After surgery, the animals were
monitored daily for signs of stress, including adaptation
of a crouched posture, changes in appearance of hair and
weight loss. Ten to 15 days after the recovery period, the
animals were humanely killed by CO2 asphyxiation and
the nodose ganglia were dissected. In a separate study,
we labelled neurons with fibres projecting deep into the
lung to compare duodenal and pulmonary innervating
neurons. Five Sprague–Dawley male rats (200 g; Harlan
Laboratories) were deeply anaesthetized with a mixture
of isofluorane and then given transdermal injections of
5% DiI (10 μl) into the right and left lungs using a 50 μl
Hamilton syringe. Postmortem analysis showed diffusion
of the dye into the large bronchi and vessels in three
of five animals. The animals were humanely killed by
CO2 asphyxiation, 7–14 days postinjection. Retrogradely
labelled nodose ganglia neurons were identified using a
Ti microscope (Nikon, Tokyo, Japan) equipped with a
tetramethylrhodamine epifluorescence filter.
Isolation and culture of vagal sensory neurons
Sprague–Dawley rats (160–240 g; Harlan Laboratories)
were killed by CO2 asphyxiation and the nodose
ganglia were dissected and placed in a 35 mm
culture dish containing Ca2+- and Mg2+-free Hanks’
balanced salt solution with penicillin and streptomycin
(Heldsinger et al. 2011). Desheathed ganglia were
sliced into small fragments and placed in a 1.5 ml
centrifuge tube containing digestion buffer (dispase
II; Roche Diagnostics, Life Science, Indianapolis, IN,
USA) and collagenase IA (Life Technologies, Invitrogen)
(1 mg ml–1). After incubation at 37°C for 60 min, cells
were dispersed by gentle trituration through Pasteur
pipettes and washed in Dulbecco’s modified Eagle
medium(DMEM;LifeTechnologies, Invitrogen).Thecells
were resuspended in L-15 medium (Life Technologies,
Invitrogen) containing 10% fetal bovine serum (FBS),
plated onto poly-L-lysine-coated (100 μg ml–1) coverslips
for 30 min and cultured in DMEM with 10% FBS at
37°C. Neurons were stuck to coverslips and maintained
in culture for 16–48 h at 37°C before recording.
Neuron transfection with small interfering
RNA (siRNA)
Primary vagal ganglia neuronal cultures were supple-
mented with (1.5 mg ml–1) of siRNA Kir6.2 (sc-42629),
Erk1 (sc-156030), Erk2 (sc-156031), PI3K (si156021) and
random siRNA (sc-37007) (Santa Cruz Biotechnology,
Dallas, TX, USA) at 37°C (Heldsinger et al. 2011). To aid
in the identification of transfected neurons, siRNAs were
conjugatedwith cyanine 3 (Cy3) or FITCfluorescent label.
Duplex siRNAs were labelled with the method described
in the Silencer siRNA labelling kit (Life Technologies,
Ambion, Austin, TX, USA). Patch clamp recordings
were conducted only on neurons positively identified as
containing Cy3 or FITC label. After 3 h, media containing
siRNA were aspirated and replaced with DMEM/F-12
media containing 100 mg dl–1 glucose and 10% FBS
supplementedwith gentamycin (100Uml–1). Theneurons
were cultured for72–96hat 37°Cina5%CO2 atmosphere.
Whole-cell patch clamp recordings were performed on
cultured vagal sensory neurons within 72–96 h after
siRNA transfection of enhanced green fluorescent protein
(EGFP)-positive neurons.
Whole-cell patch clamp electrophysiology
All measurements were made in a physiological saline
solution composed of (inmM): 140NaCl, 5 KCl, 2 CaCl2, 1
MgCl2, 5 glucose and 10 HEPES; pH adjusted to 7.3 with
NaOH (Grabauskas et al. 2010). Whole-cell recordings
were acquired using borosilicate glass electrodes with
resistance between 3 and 6 M (A-M Systems,Sequim,
WA, USA) backfilled with a saline solution composed
of (in mM): 130 potassium gluconate, 10 HEPES, 10
EGTA, 1.0 MgCl2, 2.5 CaCl2, 1.0 ATP and 0.3 GTP;
pH adjusted to 7.3 with KOH. Current and voltage
recordings were acquired from discrete isolated vagal
sensory neurons using an Axopatch 200B Amplifier
(MolecularDevices, Sunnyvale, CA,USA) filtered at 2 kHz
using a four-pole low-pass Bessel filter. For data analysis,
signals were digitized using an analog-to-digital converter
(Axon Digidata 1322B; Molecular Devices), stored and
analysed on a personal computer running pCLAMP
9 software (Molecular Devices). The input resistance was
calculated by measuring the neuron membrane potential
displacement from–60mV in response to a –10pAcurrent
pulse.
Western blotting
Vagal ganglia neurons were isolated and harvested
in accordance with a technique described previously
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
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(Heldsinger et al. 2011). Briefly, the neurons were
incubated with inhibitors for 30 min before a 10-min
stimulation with ghrelin. The reaction was stopped by the
addition of 1 ml of chilled PBS buffer. After washing, lysis
buffer (30μl) with protease inhibitor (Roche Diagnostics,
Life Science) was added to the culture dish and the
cells were incubated for 15 min at 4°C. The lysate was
centrifuged at 14,000 g for 10 min. Protein samples
were then run on 12% Ready Gel Tris-HCl (Bio-Rad
Laboratories,Hercules, CA) for 1.5 h at 80V. Proteinswere
then transferred to PVDF membranes for 1 h at 80 V. The
membraneswere blockedwith StartingBlockT20blocking
buffer (Life Technologies, Waltham, MA, USA) at room
temperature, probed with primary antibodies against
Erk1/2 (Cell Signaling Technology, Danvers, MA, USA),
phosphorylated-Erk1/2 (Cell Signaling Technology),
phospho-PI3K (Cell Signaling Technology) and GAPDH
(Santa Cruz Biotechnology) at a dilution of 1:1000 at 4°C
overnight, and then washed in Tris-buffered saline for 1 h.
The membranes were probed with corresponding horse-
radish peroxidase-conjugated secondary antibodies at a
dilution of 1:2000. The resulting bands were scanned with
an Epson Stylus Photo R2400 (Epson Corp., Long Beach,
CA,USA) andanalysedusing ImageJ (NIH,Bethesda,MD,
USA).
Peptides and drugs
Ghrelin, leptin and CCK-8 (R&D Systems, Minneapolis,
MN, USA) were prepared on the day of the experiment by
diluting50μl aliquots of 10–5 M stock solution. Forwestern
blotting, the role of Gαi/o G protein-coupled receptors
in the signalling process was examined by overnight
treatment of neurons with 1μl ml–1pertussis toxin (PTx),
a bacterial toxin that catalyzes G protein heterotrimer
interaction with receptors. For electrophysiology studies,
PTx was included in the recording electrode internal
solution before ghrelin stimulation (Barbier & Cortina
1988; Grabauskas et al. 2007). A phospholipase C (PLC)
inhibitor U73122 (10 μM) was used to examine the
involvement of PLCs (Yule & Williams, 1992). The
non-selective protein kinase inhibitor H7 (30 μM; R&D
Systems) was used to determine whether protein kinases
play a role in mediating the actions of ghrelin (Quick et al.
1992). Similarly, SQ 22536, an adenylate cyclase inhibitor
(100μM; R&D Systems) (Heldsinger et al. 2014), was used
to clarify the role of adenylate cyclase in the mediation
of ghrelin signalling. Calphostin C, a protein kinase C
(PKC) agonist (1 μM, R&D Systems) (Au et al. 2006;
Grabauskas et al. 2007), was used to determine whether
PKC plays a role. Wortmannin (100 nM; R&D Systems)
was used to inhibit P13K (Heldsinger et al. 2011). All
agonists, antagonists and their controls were prepared on
thedayof the experimentbydiluting stock solutions stored
at appropriate temperatures. The concentrations of the
chemicals used were those shown to be effective in the
literature cited.
RT-PCR
RNA was extracted from the vagal ganglia using TRIzol
(Life Technologies, Ambion), in accordance with the
manufacturer’s instructions. Reverse transcription was
performed using 5 μg of total RNA. The resultant cDNAs
were used for PCR with primer sets targeting Kir6.2
(sense: AGACCACCAGCCCGGAGGGCG, antisense GG
GCACTTTAACGGTGTTCCC; GenBank accession num-
ber NM 031358), Erk1 (sense: GGCTGCATTCTGGCT
GAGATG-3, antisense: CTCCATGTCAAAGGTGAATGG,
GenBank accession number NM 053842), Erk2 (sense:
TCGTACATCGGAGAAGGCGCC, antisense: TAATTTC
TGGAGCTCTGTACC, GeneBank accession number
NM 053842), PI3K (sense: ACCTGTTAGGGATTCTA
GCCC, antisense: TGTCGTAACTCTGCAGGGTT,
GenBank accession number NM 013005) and GAPDH
(sense: CACCACCATGGAGAAGGCTGG, antisense:
GGGCACTTTAACGGTGTTCCC, GenBank accession
number AF 106860). GAPDH served as an internal
control. PCR was performed with Taq DNA polymerase
(Promega, Madison, WI, USA) through 30 cycles of
denaturation (30 s at 94°C), annealing (30 s at 50°C)
and extension (30 s at 72°C), followed by final extension
(10 min at 72°C). The PCR products were loaded in
a 1.2% Tris-borate-EDTA-buffered agarose gel, and
the bands were visualized after gel electrophoresis by
ethidium bromide staining and UV light illumination.
The resulting bands were scanned with an Epson Stylus
Photo R2400 (Epson Corp.) and analysed using ImageJ
(NIH).
siRNA and in vivo electroporation
Kir6.2 (sc-42629), Erk1 (sc-156030), Erk2 (sc-156031),
PI3K (si156021) and random siRNA (sc-37007)
were purchased from Santa Cruz Biotechnology. The
pEGFP-N1 vector (BD 6085-1), which encodes the
Aequorea victoria GFP, was purchased from BD Bio-
sciences (San Jose, CA, USA). The in vivo electroporation
was performed as described previously (Saito et al. 2006;
Zhou et al. 2011). Each rat was anaesthetized and placed
supineonacustom-made surgical plate.Body temperature
wasmaintained at 37± 1°Cwith a homeothermic blanket
system (Harvard Bioscience, Holliston, MA, USA) as
described previously (Fan et al. 2009). The vagal nodose
ganglia were exposed by way of a ventral approach. The
incision was made from the midline of the neck. With
the use of a surgical operating microscope, the caudal
end of the ganglion with the attached vagus nerve was
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
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separated from the adjacent cervical sympathetic trunk
and carotid artery. The vagus ganglion was carefully iso-
lated, and the area was moistened with saline. A piece of
filter paper soaked with protease (type XIV, 0.3 mg ml–1)
was applied to the ganglion for 15 min. A bevelled glass
micropipette with tip diameter 35–45 μm (Clunbury
Scientific, Bloomfield Hills, MI, USA) was filled with a
2:1 mixture of Kir6.2, PI3K, Erk1 and Erk2 siRNA (10μM;
14μl–1) or control siRNA(10μM;14μl–1)withpEGFP-N1
vector (1 μg μl–1; 7 μl). The micropipette, connected to
a nanopump (PV830 Pnematic PicoPump; World Pre-
cision Instruments, Sarasota, FL, USA), was guided by a
micromanipulator through a small incision on the surface
of the nodose ganglion. siRNAs and pEGFP-N1 vector
were then injected into the left and right vagal ganglia
(bilateral; 20 nl each). The micropipette was left in the
ganglion for 10 min and then slowly withdrawn. A pair
of stainless steel electrodes was placed on the ganglion
15 min after the injection. The gap between the electro-
des was fixed at 2 mm. Square-wave electric pulses were
delivered by an isolated pulse stimulator (Model 2100;
A-M Systems). A train of square-wave pulses with pulse
duration of 20 ms was delivered at 50 V cm–1 at a
frequency of 1 Hz, followed by the same stimulation with
the opposite polarity. In a separate study, a control group
of animals was treated with bilateral electroporation of
a mixture of control siRNA (Santa Cruz Biotechnology)
and pEGFP-N1. Transfection efficiency was assessed by
measuring GFP expression, specific protein immuno-
reactivity, mRNA expression and protein expression. GFP
expression, which is a novel genetic reporter system, was
measured using fluorescence microscopy with excitation
at 488 nm. Because the specific target siRNA construct
was packaged with GFP reporter gene, the distribution
of siRNA expression and GFP expression probably over-
laps. Research has shown that transfection of siRNA
into neurons in the CNS has a maximal effect 3–6 days
post-transfection, with silencing lasting up to 2 weeks.
Studies were performed 5 days after electroporation. We
determined the optimal conditions for electroporation
and GFP expression in accordance with the parameters:
voltage (1–80 V), duration (5–120 ms), pulse number
(1–12 times) and frequency of pulse delivery (0.5–10 Hz).
The optimal stimulation paradigm was 50 V cm–1 with
10 pulses delivered at 1 Hz (20 ms duration). These
parameters weremost effective to reduce the targeted gene
expression in the vagal sensory ganglia with the least cell
damage.
Recording of single-unit vagal sensory neuronal
activity
The animals were anaesthetized with a mixture of
xylazine and ketamine (13 and 87 mg kg–1 body weight,
respectively). Our data show that this anaesthesia was
associated with significant increase in blood glucose
concentration to 220 mg dl–1. To investigate the possible
interference of elevated blood glucose on the electro-
physiological recording, we performed similar single-unit
recordings in rats anaesthetizedwithphenobarbital, which
has no effect on blood glucose (n = 4). We showed that
the neuronal responses to CCK-8 and leptin stimulation
remained the same as those observed in rats anaesthetized
with xylazine and ketamine. Recording of single-unit
vagal sensory activity was performed as described pre-
viously by Li et al. (1999). Supplemental doses of
the anaesthetic agents were administered as needed to
maintain a deep level of anaesthesia andmuscle relaxation.
The animals were ventilated with a respirator, and a
tracheal tube permitted artificial ventilation with room
air (75–85 strokes min–1; tidal volume 3.5–4.0 cm3).
Rats were placed in a small animal stereotaxic frame
(David Kopf Instruments, Tujunga, CA, USA). Body
temperature was maintained with a special heating pad.
The right vagal sensory ganglion was exposed by a short
dorsal approach. The bevelled glass micropipette filled
with 1.0 M KCl and neurobiotin tracer (0.2%; Vector
Laboratories, Burlingame, CA, USA) was lowered into
the nodose ganglion. A reference electrode was placed
on a skin incision near the recording electrode. Neuro-
nal discharges recorded were amplified by a high-input
impedance preamplifier (A-M Systems), monitored with
anoscilloscope and audiomonitor anddisplayed, and then
stored on a computer usingAxon tape software (Molecular
Devices).
Juxtacellular labelling and histological identification
of recorded neurons
On completion of the single-unit recording experiment,
recorded neurons were labelled by injecting neurobiotin
using the technique of juxtacellular iontophoresis (Gao
et al. 2006). Continuous electrophysiological control
ensured the viability of the neurons. The electrode was
positioned as close to the recorded neuron as possible.
Using the bridge circuit of the recording amplifier, the
marker was applied in pulses (250 ms on and 250 ms off).
The intensity of the DC current was gradually increased
from 2 to 8 nA.
Immunocytochemistry
Immunocytochemistry studies to localize the inwardly
rectifying Kir6.2 (Santa Cruz Biotechnology), Erk1/2
(Cell Signaling Technology) and GSH-R1a (Santa Cruz
Biotechnology) were performed on vagal sensory neurons
as described previously (Helsinger et al. 2012). Following
anaesthesia with urethane, a transcardial perfusion was
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
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performed with ice-cold heparinized PBS and sub-
sequently with fixative containing 4% paraformaldehyde,
0.2% picric acid and 0.35% glutaraldehyde in phosphate
buffer (0.1mol l–1, pH7.4). The left and right vagal sensory
ganglia were removed and placed in the same fixative for
2 h at room temperature and then in 25% sucrose in
PBS (0.1 mol l–1) overnight at 4°C. The ganglia were cut
into 5 μM longitudinal sections using a precision cryostat
(Leica Microsystems, Wetzlar, Germany). The sections
were collected in serially ordered sets, thaw-mounted on
gelatin-chromium coated slides and stored at −70°C. For
permeabilization and background reduction, sections of
the vagal ganglia were incubated in 5% normal donkey
serum in PBS for 1 h at room temperature. Staining was
performed using the primary antibodies against Kir6.2,
Erk1/2 and GSH-R1a (all at a dilution of 1:200). The
primary antibodies were diluted in PBS containing 2%
normal donkey serum, 0.3% Triton X-100 and 0.1%
sodium azide. Tissues were incubated overnight at room
temperature, washed in PBS and then exposed for 1 h
to species-specific Alexa Fluor 488- (Life Technologies,
Molecular Probes) and Cy3-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) and AMCA streptavidin (Vector
Laboratories) diluted in PBS containing 0.3% Triton
X-100 (dilution 1:200). The sections were coverslipped
and sealed. The specificity of antibodies was demonstrated
by excluding the primary antibodies or secondary anti-
bodies during the staining procedure, which resulted in
complete abolition of staining of the vagal ganglia. All
preparations were examined with a BX51 epifluorescence
microscope (Olympus, Tokyo, Japan) equipped with
a digital camera. The images were analysed by using
filter combinations that enabled separate visualization of
multiple fluorophores. Images were stored and analysed
with Image-Pro Plus software (Media Cybernetics,
Rockville, MD, USA) or Photoshop CS2 (Adobe Systems,
San Jose, CA, USA). The digital images taken by the
confocal microscope were analysed with LSM Image
Browser (Carl Zeiss, Oberkochen, Germany) and Photo-
shop CS2 (Adobe Systems).
Food intake studies and effects of electroporation
with Kir6.2 siRNA
Before starting the food intake studies, the rats were
randomly divided into two groups of five rats each and the
right and left nodose ganglion were electroporated with
random siRNA (sc-37007) or Kir6.2 siRNA (sc-42629;
Santa Cruz Biotechnology). Feeding studies were initiated
5 days after electroporation. The rats were starved over-
night (12 h) with free access to water. On the day of the
experiment, the control rats were given a saline injection
and the study rats were given an injection of ghrelin (25μg
kg–1 I.P.). The feeding study was initiated at 09.00 h. The
rats were given weighed food and their cumulative food
intake was recorded at 1 h intervals over 3 h, as described
by Schwartz et al. (1996).
Statistical analysis
All data are expressed as the mean ± SEM. P < 0.05
was considered statistically significant (two-way anova or
Fisher’s exact test). All statistical analyses were performed
using InStat (GraphPad Software, San Diego, CA,
USA).
Results
Ghrelin inhibits vagal sensory neurons via activation
of KATP channels
Whole-cell current clamp recordings revealed that
extracellular superfusion of ghrelin (30 nM, saturating
concentration) hyperpolarized 19 of 59 (32%) recorded
neurons from −56 ± 3 mV to −62 ± 3 mV (Fig. 1A).
Of the 59 recorded neurons, 19 and 15 were identified
projecting to duodenum and lungs, respectively, using
the DiI retrograde labelling technique. Nine of 19 (47%)
duodenum-projecting neurons and two of 22 (9%) of
lung-projecting neurons responded to 30 nM ghrelin.
Therefore, it appears that upper gut-projecting nodose
ganglia neurons are much more sensitive to ghrelin than
those projecting to the lung. The hyperpolarization was
associated with a decrease in neuronal input resistance
from 320 ± 9 to 281 ± 28 M (78% of control,
n = 8, P < 0.01), a reduction in the number of action
potentials at double the strength of the rheobase from
5.5 ± 2.5 to 2.1 ± 1 (35% of control, P < 0.001) and an
increase in action potential threshold (Fig. 1A–C). These
changes indicate that ghrelin decreased the nodose ganglia
excitability.
Analysis of current–voltage relationships before and
after ghrelin application revealed that the curves crossed
at−105mV, which is close to the K+ ion reversal potential
under the conditions recorded (Fig. 1D). These findings
suggest that the actions of ghrelin are mediated by the
opening of K+ channels.
Recent studies from our laboratory indicate that
the vagal KATP channels play an important role in
metabolic sensing (Grabauskas et al. 2010; Grabauskas
et al. 2013). We examined whether KATP channels
mediate ghrelin-generatedoutward currents. Extracellular
application of tolbutamide (200 μM), a KATP channel
inhibitor, reversed ghrelin currents (n = 5) (Fig. 2A).
Moreover, concurrent application of tolbutamide and
ghrelin blocked the ghrelin currents by 89% (4.5 ± 3 mV,
n = 9, P < 0.001) (Fig. 2B).
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To confirm the involvement of KATP channels, we
silenced the Kir6.2 subunit using siRNA (Grabauskas
et al. 2010; Grabauskas et al. 2013). The Kir6.2 siRNA
was tagged with a Cy3 fluorescent label, which permitted
identification of the transfected neurons (Fig. 2C,
inset). After incubation for 72–96 h, we examined the
responsiveness of Cy3-positive vagal neurons to the
extracellular application of ghrelin (30 nM). The trans-
fected neurons (n = 30) did not respond to either ghrelin
(30 nM) or tolbutamide (200 μM) (Fig. 2C).
We performed immunohistochemical staining of the
vagal nodose ganglia to demonstrate that GHS-R1a
colocalizes with the Kir6.2 channel subunit. Our studies
showed intense staining of Kir6.2 and GHS-R1a in 72%
and 40% of nodose neurons, respectively (Fig. 2D–G).
Among the GHS-R1a-positive neurons, 97% expressed
Kir6.2. Thus, the electrophysiological and immuno-
cytochemistry data support the premise that the
inhibitory actions of ghrelin are mediated by the opening
of KATP channels, resulting in membrane potential
hyperpolarization.
Ghrelin inhibits inward currents generated by leptin
and CCK
Weperformedwhole-cell voltage clamp studies to examine
the interaction between ghrelin and leptin and also
between ghrelin andCCK.We showed that ghrelin (30 nM)
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Figure 1. Ghrelin inhibits vagal sensory neurons
A, continuous membrane potential recording from duodenum-projecting neuron (DiI labelled, inset) showing that
ghrelin (30 nM; bar) hyperpolarized the membrane potential and reduced the neuronal input resistance. Negative
membrane potential deflections display the neuron potential in response to DC current pulses (−100 pA, 500 ms).
B, current responses showing that extracellular application of ghrelin (30 nM) hyperpolarized the recorded neuron.
This hyperpolarization was associated with a decrease in neuronal input resistance, as well as a decrease in the
number of action potentials evoked by a DC current pulse of amplitude 140 pA (double rheobase) from 6 to 1.
C, ghrelin modulates vagal sensory neuron excitability by reducing the neuronal input resistance (Rin), increasing
the threshold for action potential initiation and reducing the number of action potentials evoked by a current
pulse of the amplitude of double rheobase (n = 8, values are the mean ± SEM, ∗P < 0.05 compared to controls).
D, current–voltage relationships acquired under control conditions and during ghrelin application showing that the
effect reversed at approximately −105 mV, close to the estimated K+ equilibrium potential under the conditions
recorded.
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and leptin (10 nM) generated outward and inward currents
of maximal amplitude of 44 ± 5 pA (n = 5) and
38 ± 6 pA (n = 5), respectively (Fig. 3A). Application
of leptin following ghrelin resulted in no significant
deviation from the baseline current (5.1 ± 8 pA, Fig. 3A,
lower).
In a separate series of experiments, we examined the
interaction between ghrelin and CCK. Superfusion of
CCK-8 (30nM) generated an inward current of 88±11pA.
Repeated superfusion of CCK-8 in the presence of ghrelin
(30 nM) generated an inward current of 40 ± 8 pA
(n= 5) (Fig. 3B). Analysis of leptin- andCCK-8-generated
currents, either alone or in the presence of ghrelin, showed
that the resulting currents are the sum of ghrelin and
leptin/CCK-8-evoked currents (Fig. 3C). Our findings
suggest that these currents operate via independent ion
channels.
Signal transduction pathways used by ghrelin
to activate KATP channels in the nodose ganglia
Protein phosphorylation plays an important role in the
modulation of neuronal excitability. Previous studies
identified specific sites on the Kir6.2 channel that are sub-
strates for G protein-activated serine/threonine kinases
and also showed that activation of these sites contributes
to short- and long-term regulation of current amplitude
and kinetics (Be´guin et al. 1999). We hypothesize
that ghrelin stimulates the Gαi–PI3K–mitogen-activated
protein kinase (MAPK)/Erk1/2 pathway to activate the
KATP channels. To test this hypothesis, we examined the
effect of ghrelin onPI3K andErk1/2 expression in cultured
rat nodose ganglia neurons. Nodose ganglia neurons were
stimulated with 0–100 nM ghrelin for 60 min; PI3K
was significantly increased at 3, 10 and 30 nM. The
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Figure 2. Ghrelin inhibits vagal sensory neurons via activation of KATP channel
A, continuous current recording showing that tolbutamide (200 μM), a KATP channel inhibitor, reversed the current
induced by ghrelin (30 nM) in a duodenum-projecting neuron (DiI labelled, inset). B, representative continuous
current recording showing that extracellular application of tolbutamide (200 μM) generated an inward current
(10 pA). Subsequent application of ghrelin (30 nM) failed to induce an outward current. C, silencing the Kir6.2
channel subunit in a vagal sensory neuron using Kir6.2 Cy3-labelled siRNA abolished both ghrelin and tolbutamide
currents. The inset shows a Kir6.2 Cy3-siRNA transfected/labelled neuron. D–F, photomicrographs showing
anti-Kir6.2 (green) and anti-GHS-R1a (red) immunoreactivities in vagal ganglia cross-sections. Superimposition
of the green and red images showing that most anti-GHS-R1a immunoreactivity colocalizes with anti-Kir6.2
(yellow). Scale bar, 100 μm. G, percentage of neurons in vagal ganglia expressing Kir6.2 and GHS-R1a, as well as
both Kir6.2 and GHS-R1a. The data are based on counts from five cross-sections.
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
J Physiol 593.17 KATP channels and ghrelin 3981
dose–response curve showed a bimodal distribution with
a maximal increase at 10 nM ghrelin (Fig. 4A, Fig. S1A).
Similarly, ghrelin-stimulated Erk1/2 phosphorylation was
significant at 10, 20 and 30 nM, with a maximal
increase at 30 nM ghrelin compared to control (Fig. 4B,
Fig. S1B).
Examination of the signal transduction cascade
with western blot analysis revealed that ghrelin
(30 nM)-induced phosphorylation of Erk1/2 was blocked
by PTx (1 U ml–1), a Gαi protein inhibitor, and
wortmannin (100 nM), a PI3K inhibitor (Fig. 4C, Fig.
S1C). By contrast, U73122 (10 μM), a PLC inhibitor;
calphostin C (1μM), a PKC inhibitor; SQ 22536 (100μM),
an adenylate cyclase inhibitor; and H7 (30 μM), a protein
kinase A (PKA) inhibitor, did not block ghrelin-induced
Erk1/2phosphorylation (Fig. 4C, Fig. S1C). To confirmthe
involvement of PI3K in cells transfected with PI3K siRNA,
ghrelin-stimulated Erk1/2 expression was significantly
inhibited (> 90%, n = 6) (Fig. 4D, Fig. S1D). Western
blotting showed that transfectionwith PI3K siRNA caused
a 76 ± 4% reduction in PI3K expression.
To confirm that ghrelin acts via the Gαi–PI3K–
MAPK/Erk1/2 pathway to modulate nodose ganglia
excitability, we performed whole-cell current clamp
recordings. Compared to controls (Fig. 5A), neurons
dialysed with PTx (1 μ ml–1, n = 12, P < 0.05) (Fig. 5B)
showed no response to ghrelin (30 nM). Similarly, trans-
fection with PI3K siRNA (n = 8, P < 0.05) (Fig. 5C)
or Erk1/2 siRNA (n = 8, P < 0.05) (Fig. 5D) also
abolished ghrelin currents. These results are summarized
in a histogram (Fig. 5E). Thus, protein expression studies
and electrophysiological recordings indicate that ghrelin
inhibits vagal sensory neurons via the Gαi–PI3K–Erk1/2
pathway.
Silencing PI3K, Erk1/2 and KATP abolishes the
inhibitory actions of ghrelin on leptin- and
CCK-stimulated nodose neuronal activities in vivo
In vivo single-unit discharges of vagal primary afferent
neurons innervating the gastrointestinal tract were
recorded from rat nodose ganglia as described previously
(Li et al. 1999). Data were collected from 84 recordings
of single nodose ganglia neurons in 18 rats. Under basal
conditions, all units were either silent or displayed very
low spontaneous activities (0–5 spikes per 20 s bin).
All 84 units were activated by electrical stimulation of
the subdiaphragmatic vagus nerve. Ghrelin (30 μg kg–1
I.V.) did not affect the basal firing rates. However, it
markedly reduced nodose neuron firing stimulated by
leptin and CCK-8 (Fig. 6). As shown in Fig. 6A, the
infusion of leptin (225 μg kg–1 I.V.) caused the neuro-
nal firing rates to increase from a basal of 0 ± 1 to
14 ± 5 spikes per 20 s (n = 6, P < 0.05). Similarly,
administration of CCK-8 (30 μg kg–1) also increased
the firing rate to 23.5 ± 3.5 spikes per 20 s (n = 5,
P < 0.05)(Figs 6B and 7A). However, when leptin or
CCK-8 were administered 30 s after ghrelin injection, the
increased firing rates were reduced to 5.1 ± 3 and 9 ± 2.3
spikes per 20 s, respectively (n = 5–6, P < 0.05)(Fig. 6A
and B).
We genetically silenced the Kir6.2 channel subunit
by electroporation of the right nodose ganglia with
random (control) or specific Kir6.2 siRNA. RT-PCR data
demonstrated that, 5 days after electroporation of the
nodose ganglia with Kir6.2 siRNA, Kir6.2 mRNA was
reduced by 75% (n = 3) (Fig. 6C). To ensure that neuro-
nal discharges were recorded from Kir6.2-silenced and
GHS-R1a-expressing neurons, the recorded neurons were
labelled with neurobiotin after the electrophysiological
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Figure 3. Ghrelin and leptin or CCK-8
activate different antagonistic currents
A, representative current recording in response
to ghrelin (30 nM, upper trace), leptin (10 nM,
middle trace), and ghrelin and leptin combined
(lower trace). Note that ghrelin generated an
outward current (upper trace) that was slowly
decaying. However, when ghrelin was paired
with leptin, the outward current was reversed.
B, representative current recording in response
to CCK-8 (30 nM) and, 10 min later, in
response to ghrelin (30 nM) and CCK-8
(30 nM). Note that the second application of
CCK-8 generated a current that was similar in
amplitude but ‘displaced’ by the
ghrelin-generated current. The shift from the
baseline generated by the first and second
applications of CCK-8 was 78 pA and 42 pA,
respectively. C, pooled data of maximum
current amplitudes generated by ghrelin
(n = 5), leptin (n = 5), CCK-8 (n = 5) and
ghrelin-leptin/CCK-8 groupings (n = 5).
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recordings (Fig. 7A and 7B). Our immunohistochemical
data demonstrated that Kir6.2 gene silencing reduced the
number of anti-Kir6.2-positive cells from 72% to 15%
(n = 5). Only neurons that showed no immunoreactivity
to anti-Kir6.2 but were immunoreactive to anti-GHS-R1a
were included in our data analysis (Fig. 7B). As shown
in Fig. 6A, B and D, after silencing Kir6.2, ghrelin failed
to inhibit leptin- (n = 6) and CCK-8- (n = 6) evoked
neuronal firing.
In separate studies, we showed that silencing the gene
expression of Erk1/2 or PI3K in the nodose ganglia
by electroporation of specific siRNAs also abolished the
inhibitory actions of ghrelin (30 μg kg–1 I.V.) on leptin-
(n = 6) and CCK-8- (n = 6) induced responses (Fig. 6E
and F). RT-PCR data demonstrated that, 5 days after
electroporation of Erk1/2 siRNA and PI3K siRNA, the
gene expression of Erk1/2 and PI3K was reduced > 80%.
Silencing Kir6.2 in the nodose ganglia abolishes the
orexigenic actions of ghrelin on feeding
To provide direct evidence that the KATP channel in the
nodose ganglia mediates the orexigenic actions of ghrelin,
we performed feeding studies in three groups of rats
after a 12 h fast: (i) control rats treated with I.P. saline;
(ii) control rats treatedwith ghrelin (30μg kg–1 I.P., 30min
before feeding); and (iii) rats 5 days after silencingofKir6.2
Figure 4. Ghrelin stimulates p-PI3K and p-Erk1/2 in the nodose ganglia
A, western blot showing that ghrelin stimulates nodose ganglia p-PI3K in a dose-dependent manner (n = 6).
B, western blot showing that ghrelin stimulates nodose ganglia p-Erk1/2 in a dose-dependent manner (n = 6).
C, ghrelin (20 nM)-stimulated p-Erk1/2 was inhibited by wortmannin (100 mM) and PTx (1 U ml–1) but not by
PLC inhibitor U73122 (10 μM), PKC inhibitor calphostin C (1 μM), adenylate cyclase SQ 22536 (100 μM) or PKA
inhibitor H7 (30 μM) in the nodose ganglia (n = 5–6, ∗P < 0.05 compared to basal controls; #P < 0.05 compared
to stimulation by ghrelin). D, Western blot showing ghrelin-stimulated Erk1 and Erk2 mRNA expression in vagal
ganglia 96 h after transfection with random siRNA but not with PI3K siRNA [n = 4, ∗P < 0.05 compared to basal
control; ∗∗P < 0.05 compared to nodose ganglia transfected with control (random) siRNA].
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
J Physiol 593.17 KATP channels and ghrelin 3983
in the nodose ganglia and treated with ghrelin (30μg kg–1
I.P., 30 min before feeding). In the control group whose
right and left nodose ganglia were electroporated with
random siRNA, I.P. injection of ghrelin stimulated food
intake in the first, second and third hours of feeding
compared to rats treated with I.P. saline (n = 6, P < 0.05)
(Fig. 8A). Silencing Kir6.2 expression in both nodose
ganglia completely prevented the orexigenic actions of
ghrelin during the first 3 h of feeding (n = 6, P < 0.05)
(Fig. 8A). Indeed, the accumulative food intake in the first,
second, and third hours was less compared to that in the
control group, which was not treated with ghrelin. This
suggests that the KATP channel in the nodose ganglia also
mediates the orexigenic actions of endogenous ghrelin.
Discussion
We have shown for the first time that ghrelin
modulates the excitability of the nodose ganglia by
activating a KATP conductance. We provide substantive
experimental evidence to support this conclusion:
(1) immunocytochemistry studies showed that almost
all GSH-R1a-containing neurons in the nodose ganglia
expressed KATP channels; (ii) analysis of current–voltage
relationships for the ghrelin-induced current exhibited a
negative slope conductance that reversed at approximately
−105 mV, which is consistent with activation of K+
ion channels under the recording conditions; (iii)
application of the KATP antagonist tolbutamide abolished
ghrelin-induced currents, as shown by our patch clamp
studies; (d) in vitro and in vivo studies demonstrated that
the inhibitory actions of ghrelin were abolished in rat
vagal sensory neurons transfected with Kir6.2 siRNA; and
(e) silencing Kir6.2 in vagal sensory neurons abolished the
orexigenic actionsof ghrelinon food intake.Thesefindings
indicate that ghrelin inhibits vagal sensory neurons via
activation of KATP channels. In addition, our patch clamp
recordings and protein expression studies showed that
the Gαi–PI3K–Erk1/2–KATP signalling cascade mediates
the actions of ghrelin (Fig. 8B). The resulting hyper-
polarization rendered the nodose ganglia less responsive
to signals evoked by anorexigenic hormones.
ATP-sensitive K+ channels couple cell metabolism to
electrical activity in a variety of cell types by regulating K+
fluxes across the cell membrane. Heightened metabolism
leads to channel closure, membrane depolarization and
electrical firing. Reduced metabolism, in contrast, opens
KATP channels and decreases electrical activity. In endo-
crine cells, KATP channels play a critical role in the release
of hormones, such as insulin from pancreatic β cells
(Ashcroft et al. 1984) and glucagon from pancreatic α cells
(Go¨pel et al. 2000). In the CNS, KATP channels modulate
electrical activity and neurotransmitter release (Amoroso
et al. 1990; Avshalumov & Rice, 2003), whereas, in the
heart, KATP channels mediate cardioprotection against
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Figure 5. Electrophysiological evidence that Gαi, PI3K and Erk1/2 mediate the actions of ghrelin in the
nodose ganglia
A, representative current recording showing that extracellular application of ghrelin (30 nM) generated an outward
current (n = 12). B, representative current recording showing that inclusion of PTx (1 U ml–1) in the recording
electrode media abolished ghrelin-induced currents (n = 9). C, representative current recording showing that
ghrelin-induced currents were abolished in PI3K siRNA-transfected neurons (n = 10). D, representative current
recording showing that ghrelin-induced currents were abolished in Erk1 and Erk2 siRNA-transfected neurons
(n = 12). E, ghrelin currents (n = 12) were inhibited by PTx (n = 9) and by transfection of nodose ganglia neurons
with PI3K siRNA (n = 10) or Erk1 and Erk2 siRNA (n = 12). ∗P < 0.05 compared to ghrelin-treated neurons.
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ischaemia/reperfusion injury (Suzuki et al. 2002). In the
present study, we show that KATP channels mediate the
inhibitory actions of ghrelin on vagal sensory neurons
and we propose a mechanism to explain the actions of
ghrelin with respect to overcoming anorexigenic signals
from different origins. Plasma ghrelin levels in rats are
reported to increase during prolonged fastingwhen energy
metabolism is low (Li et al. 2009). We show that ghrelin
opens KATP channels and reduces vagal sensory neuronal
firing so that the nodose ganglia become less responsive
to stimulation by anorexigenic signals, such as CCK
and leptin. We have shown that, on feeding, nodose
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Figure 6. Kir6.2 subunit mediates the inhibitory actions of ghrelin inhibition in vivo
A, single-unit recordings in response to leptin (225 μg kg–1 I.V.) and leptin after ghrelin administration (25 μg kg–1
I.V.) from the right nodose ganglia, whichwere electroporatedwith Kir6.2 channel siRNA (lower trace). B, single-unit
recordings in response to CCK-8 (30μg kg–1 I.V.) and CCK-8 after ghrelin administration (25μg kg–1 I.V.) in the right
nodose ganglia, which were electroporated with Kir6.2 channel siRNA (lower trace). C, Kir6.2 mRNA expression
(RT-PCR) in vagal ganglia 96 h after electroporation with control (random) siRNA and Kir6.2 siRNA (n= 4, ∗P< 0.05
compared to control). D, discharges of vagal sensory neurons in response to I.V. injections of leptin and CCK-8
were inhibited by ghrelin in control siRNA-treated animals. The inhibitory actions of ghrelin were abolished in rats
whose right nodose ganglia were electroporated with Kir6.2 siRNA (n = 5–6, ∗P < 0.05 compared to control).
E, single-unit discharge in response to leptin (225 μg kg–1 I.V.) and leptin after the administration of ghrelin
(25 μg kg–1 I.V.) (upper) or CCK-8 (30 μg kg–1 I.V.) and CCK-8 after the administration of ghrelin (25 μg kg–1
I.V.) (lower) in the right nodose ganglia, which were electroporated with Erk1/2 siRNA. F, single-unit discharge
in response to leptin (225 μg kg–1 I.V.) and leptin after the administration of ghrelin (25 μg kg–1 I.V.) in nodose
ganglia treated with PI3K siRNA (upper) or CCK-8 (30 μg kg–1 I.V.) and CCK-8 after the administration of ghrelin
(25 μg kg–1 I.V.) in the right nodose ganglia, which were electroporated with Erk1/2 siRNA.
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ganglia neurons sense the blood glucose concentration
by increasing firing frequency through inactivation of
KATP channels (Grabauskas et al. 2010; Grabauskas et al.
2013). In thismanner, KATP channels in the nodose ganglia
couplemetabolism to electrical activity to regulate feeding
behaviour.
Figure 7. Immunostaining of rat nodose ganglia showing
neurons targeted for electrophysiological recording
A, photomicrographs of vagal ganglia cross-sections showing a
neuron (arrow) injected with neurobiotin (blue) after
electrophysiological recording. This neuron expresses both
anti-Kir6.2 (green) and anti-GHS-R1a (red) immunoreactivities.
Superimposition of the green and red images (overlay) showing that
most of the anti-GHS-R1a immunoreactivity colocalizes with
anti-Kir6.2 (yellow). Note that the recorded neuron labelled with
neurobiotin contains Kir6.2 and GHS-R1a immunoreactivities
(white). B, photomicrographs showing a neuron (arrow) injected
with neurobiotin (blue) after electrophysiological recording in a
Kir6.2 siRNA-electroporated animal. This neuron exhibits strong
immunoreactivity to anti-GHS-R1a (red) but little immunoreactivity to
anti-Kir6.2 (green). Note that few neurons in the overlay image
coexpress Kir6.2 and GHS-R1a (yellow). The recorded neuron (arrow
in overlay image) shows no immunoreactivity to Kir6.2 but expresses
GHS-R1a (purple).
The classic mechanism by which G protein-coupled
receptors activate Erk1/2 is through the heterotrimeric
G proteins. Ghrelin has been shown to activate
multiple signal transduction pathways in different tissues
(Maccarinelli et al. 2005; Duxbury et al. 2003; Camin˜a
et al. 2007; Mousseaux et al. 2006). In human aortic
smooth muscle cells, ghrelin activates the adenylate
cyclase–cAMP–PKA signalling pathway to inhibit muscle
contraction and proliferation (Rossi et al. 2009). Ghrelin
may stimulate angiogenesis via the PI3K/Akt-activated
mitogen-activated protein kinase kinase/Erk pathways in
rat cardiac microvascular endothelial cells (Wang et al.
2012). In the nigrostriatal system, ghrelin stimulates
the PLC–PKC cascades, which results in inhibition of
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Figure 8. Silencing the Kir6.2 channel in vagal sensory ganglia
abolishes the stimulating effect of ghrelin on food intake
A, effect of I.P. injection of ghrelin (25 μg kg–1) or saline on
cumulative food intake in rats whose vagal sensory ganglia were
bilaterally electroporated with random siRNA (control and ghrelin
groups) and Kir6.2 siRNA. ∗P < 0.05 compared to the saline group
whose nodose ganglia were treated with random siRNA control.
#P < 0.05 compared to the ghrelin-treated group whose nodose
ganglia were treated with random siRNA (n = 4 in each group).
B, schematic showing ghrelin signalling and KATP/Kir6.2 activation in
vagal sensory ganglia neurons. These findings suggest that ghrelin
binds to its receptor GHS-R1a in the nodose ganglia neuron to
dissociate Gαi and Gβγ , which activates PI3K. PI3K, in turn,
stimulates Erk1/2 to phosphorylate the Kir6.2 channel subunit,
leading to the opening of KATP channels and hyperpolarization of
the neurons. These events inhibit vagal neuron excitability.
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Kv7/KCNQ channels (Shi et al. 2013). In the nodose
ganglia, we show that ghrelin-induced phosphorylation
of Erk1/2 was blocked by PTx or wortmannin but not H7
(PKA inhibitor), SQ 22536 (adenylate cyclase inhibitor)
or calphostin C (PKC inhibitor). These findings indicate
that GHS-R1a in vagal sensory neurons is Gαi/o coupled
and activates the PI3K–Erk1/2 pathway via mechanisms
independent of PKC and/or PKA. To confirm that ghrelin
acts via theGαi–PI3K–MAPK/Erk1/2 cascade (Hawes et al.
1996) (Fig. 8B) to modulate nodose ganglia excitability,
we show that neurons dialysed with PTx, which selectively
binds to and ‘disables’ Gαi/o, fail to respond to ghrelin.
Furthermore, transfection with PI3K siRNA or Erk1/2
siRNA also abolishes ghrelin currents.
To provide direct evidence that KATP channels in the
nodose ganglia play a critical role in mediating the
orexigenic actions of ghrelin, we silenced KATP gene
expression by electroporation of the nodose ganglia
with Kir6.2 siRNA and plasmid pEGFP-N1 carrying
the GFP gene. Electroporation uses short, high-voltage
pulses to overcome the barrier of the cell membrane
(Saito, 2006). This transient permeabilization can be
used to load cells with drugs, tracers, RNA and DNA.
This approach is safe for animals and humans (Saito,
2006). We have successfully applied this technique to
introduce siRNA into nodose ganglia cells (Zhou et al.
2011) and the anterior gyrus (Fan et al. 2009). By
silencing KATP channel expression in the nodose ganglia,
without affecting the expression of this gene in other
systems, we could specifically examine the role of KATP
channels in the nodose ganglia in the mediation of the
orexigenic actions of ghrelin. We confirmed our success
in knocking down Kir6.2 gene expression by RT-PCR
and immunohistochemistry. In rats whose nodose ganglia
were treated with Kir6.2 siRNA to silence the expression
of KATP channels, ghrelin failed to inhibit leptin- and
CCK-8-evoked neuronal firing (Fig. 6). Similarly, this
group of rats also failed to respond to ghrelin in feeding
behaviour studies (Fig. 8A).
Accumulating evidence suggests that the vagus plays
an important role in the transmission of peripheral
satiety and orexigenic signals to the CNS. In addition
to receptors for anorexigenic hormones, such as CCK
(Zarbin et al. 1981) and leptin (Burdyga et al. 2002),
the vagal sensory neurons also express receptors for
orexigenic agents, such as ghrelin (Sakata et al. 2003),
orexinA (Burdyga et al. 2003), cannabinoid (Burdyga et al.
2004) and melanin-concentrating hormone (Burdyga
et al. 2006b). The nodose ganglia probably serve as a
site of interaction for various peripheral signals involved
in peptide regulation. For example, the synergistic inter-
action between CCK and leptin mediated by PI3K
and signal transducer and activator of transcription 3
signalling pathways at the level of the nodose ganglia helps
to amplify the satiety signal to control feeding (Heldsinger
et al. 2011). On the other hand, the orexigenic hormone
ghrelin and satiety factors, such as leptin and CCK, act in
opposition to regulate feeding. Recently, we showed that
ghrelin induces leptin resistance at the level of the nodose
ganglia by increasing suppressor of cytokine signalling
3 (SOCS3) expression, which impairs leptin signalling
and increases food intake in male rats (Heldsinger et al.
2014). However, increased SOCS3 expression probably
does not explain the antagonistic actions of ghrelin on
the satiety signals evoked by CCK because the actions
of CCK are not affected by SOCS3 expression in the
nodose ganglia (Heldsinger et al. 2014).Other studies have
reported that ghrelinmay reverse the satiety effects of CCK
by decreasing cannabinoid 1 and melanin-concentrating
hormone expression in the nodose ganglia (Burdyga
et al. 2006a). These novel mechanisms may explain the
antagonistic actions of ghrelin with respect to reducing
the satiety actions of individual hormones under specific
experimental conditions; however, they do not adequately
explain the actions of ghrelin with respect to over-
coming a wide range of anorexigenic signals that act by
different intracellular mechanisms. Our demonstration
that ghrelin induces hyperpolarization of the nodose
ganglia via activation of KATP channels, rendering the
nodose less responsive to satiety signals, provides a novel
mechanism to explain the ability of ghrelin to overcome
satiety signals that act via diverse signal transduction
pathways. We observed that ghrelin not only inhibits
leptin- and CCK-evoked vagal firing, but also it attenuates
satiety signals generated by bombesin and uroguanylin,
which act via different signalling cascades (WuX, Owyang
C, unpublished observations). Arnold et al. (2006)
reported that subdiaphragmatic vagal deafferentation did
not abolish eating induced by I.P. injection of ghrelin.
However, this does not rule out the possibility that ghrelin
acts on the vagal pathway to modulate satiety because our
data showed that ghrelin can act directly on the soma of
the nodose ganglia neurons.
Our observations may have pathophysiological
significance. In healthy subjects, plasma ghrelin levels
increase during overnight fasting and decline 30 min
postprandially. In obese subjects, food fails to suppress
ghrelin levels (English et al. 2002). On the other hand,
malfunctioning of the intracellular signal cascades to
activate KATP channels in the nodose ganglia may
contribute to the pathophysiology of early satiety and
eating disorders.
In conclusion, using a multilayered approach that
includes immunocytochemistry, western blotting, patch
clamp electrophysiology studies and gene silencing
techniques in cultured rat nodose ganglia neurons, as
well as in vivo single-cell electrical recordings and feeding
studies, we show that ghrelin modulates the excitability
of the nodose ganglia by activating a KATP conductance.
The resulting hyperpolarization renders the neurons less
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
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responsive to signals evoked by anorexigenic hormones.
This provides a mechanism to explain the actions of
ghrelin with respect to overcoming anorexigenic signals
that act via the vagal afferent pathways and stimulate
feeding.
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Figure S1 A, Western blot showing that ghrelin stimulates
nodose ganglia p-PI3K in a dose-dependent manner. B,
Western blot shows that ghrelin stimulates nodose ganglia
p-Erk1/2 in a dose-dependent manner. C, Western blot
showing that ghrelin (20 nM)-stimulated p-Erk1/2 was
inhibited by wortmannin (100 mM) and pertussis toxin
(PTx, 1 U mL−1) but not by PLC inhibitor U72133 (10
μM), PKC inhibitor calphostin C (1 μM), adenyl cyclase
SQ22536 (100μM) in the nodose ganglia.D, Western blot
showing that ghrelin-stimulated Erk1 and Erk2 mRNA
expression in vagal ganglia 96 h after transfection with
random but not with PI3K siRNA.
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